Antiviral prophylaxis in patients with haematological malignancies and solid tumours: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Oncology (DGHO).
about
Influenza vaccination in children being treated with chemotherapy for cancerInfluenza vaccination in children being treated with chemotherapy for cancerAntiviral prophylaxis in patients with solid tumours and haematological malignancies--update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO)Heterogeneity and evolution of thymidine kinase and DNA polymerase mutants of herpes simplex virus type 1: implications for antiviral therapy.Evidence-based guidelines for empirical therapy of neutropenic fever in Korea.Fatal cytomegalovirus disease after combination therapy with corticosteroids and rituximab for granulomatosis with polyangiitis.Hepatitis B reactivation and rituximab in the oncology practice.Rituximab-related viral infections in lymphoma patients.Disseminated herpes zoster infection initially presenting with abdominal pain in patients with lymphoma undergoing conventional chemotherapy: A report of three cases.Diagnosis & management of cytomegalovirus infections in the GI tract.Antimicrobial therapy of febrile complications after high-dose chemotherapy and autologous hematopoietic stem cell transplantation--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors : guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and OncolTherapy of HIV-associated lymphoma-recommendations of the oncology working group of the German Study Group of Physicians in Private Practice Treating HIV-Infected Patients (DAGNÄ), in cooperation with the German AIDS Society (DAIG).Non-bacterial infections in Asian patients treated with alemtuzumab: a retrospective study of the Asian Lymphoma Study Group.Database on natural polymorphisms and resistance-related non-synonymous mutations in thymidine kinase and DNA polymerase genes of herpes simplex virus types 1 and 2.Changes in the diagnosis and treatment of patients with low grade lymphoma in Germany: years 2006-2009.Spectrum of mucocutaneous manifestations in an Asian cohort of patients with leukemia.HIV-Associated Hodgkin's Lymphoma: Prognosis and Therapy in the Era of cART.Novel method for genotyping clinical herpes simplex virus type 1 isolates.Substantial variation in post-engraftment infection prophylaxis and revaccination practice in autologous stem cell transplant patients.Respiratory syncytial virus infection in infants with acute leukemia: a retrospective survey of the Japanese Pediatric Leukemia/Lymphoma Study Group.Cytomegalovirus-seropositivity has a profound influence on the magnitude of major lymphoid subsets within healthy individuals.Varicella zoster virus infection during chemotherapy in solid cancer patients.[Infections in hemato-oncology patients in intensive care. An interdisciplinary challenge].Cytomegalovirus infection and end-organ disease in Asian patients with lymphoma receiving chemotherapy.A review of the infection pathogenesis and prophylaxis recommendations in patients with chronic lymphocytic leukemia.
P2860
Q24200597-878BD9C4-D4C2-4AAD-AB38-DB438D38772BQ24241660-6DD777C8-36EB-4532-B8E8-96C83E61D612Q26801716-747F0F24-44D9-4B9A-BE7B-69935175CB68Q34035099-B5BA3312-11B6-4F0F-900A-CECB712C04D6Q35033597-2C7A8C76-7815-4E34-8BC5-AE1C2DE42B72Q35034085-201028CE-708E-46BE-BC48-9D28A51DB13DQ35583718-D73A96A7-CF55-4ED4-9559-549D8135E9D7Q36871718-BBE88E65-EFF0-4D77-81EA-D121F36520C3Q37108449-74AACB2A-7FB6-4AC9-95BE-C26497438E52Q37346001-50FBCC93-D94D-4F7C-A7FB-C95604E9E934Q38013661-22F13656-3A3E-41E9-BB08-7EC23084D530Q38081793-52680004-A638-41F2-944E-665A930F0A4DQ38210131-0554BA21-883C-471E-8118-E56423C1D80BQ38466180-0C41CADF-DA58-4A64-BB4F-CF0CF261C22EQ38598512-917EDC84-89E0-4887-BAE2-77BCC415A9BFQ39198649-4F364A6F-BC98-4721-B098-DCBBDF82EB8AQ40125142-0FB1481F-70E8-47D7-802C-67F52C39EB4BQ40512007-B47D3809-28EC-43C2-B7BC-2B9C7F2955B3Q40635959-B4828BAB-8280-4E18-8346-8E977CCEBB73Q40758750-0B364872-EEDA-420B-8F5A-11BBE15CE2DAQ40928836-C6289BA5-77A5-46A5-A347-2A824D4DA6D7Q43657953-F41F831B-A164-4A52-870C-FFED1F63CC4EQ45358990-D86A88CD-A4FB-47E4-84B2-D7416817328CQ46164114-BEE621A7-02BA-41C2-B832-F20A9DD39059Q51876038-1D726515-C9B1-4880-B668-CA6DA6C254AEQ52776107-721EA20D-F826-471C-BF0C-1977894B3FC6
P2860
Antiviral prophylaxis in patients with haematological malignancies and solid tumours: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Oncology (DGHO).
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Antiviral prophylaxis in patie ...... ematology and Oncology (DGHO).
@ast
Antiviral prophylaxis in patie ...... ematology and Oncology (DGHO).
@en
type
label
Antiviral prophylaxis in patie ...... ematology and Oncology (DGHO).
@ast
Antiviral prophylaxis in patie ...... ematology and Oncology (DGHO).
@en
prefLabel
Antiviral prophylaxis in patie ...... ematology and Oncology (DGHO).
@ast
Antiviral prophylaxis in patie ...... ematology and Oncology (DGHO).
@en
P2093
P2860
P356
P1433
P1476
Antiviral prophylaxis in patie ...... Hematology and Oncology (DGHO)
@en
P2093
A J Ullmann
G Massenkeil
Infectious Diseases Working Party, German Society for Hematology and Oncology
M Sandherr
S Schuettrumpf
P2860
P304
P356
10.1093/ANNONC/MDJ132
P577
2006-01-12T00:00:00Z